Valuation — not yet established
No valuation for PharmaCann is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($533.1M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 18 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for PharmaCann
Create free account
No card required
Funding history
18 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2024 | Early Stage VC | $35.0M | ▮ | ▮ |
| Dec 2023 | Early Stage VC | $10.0M | ▮ | ▮ |
| Nov 2023 | Early Stage VC | $5.0M | ▮ | ▮ |
| Nov 2023 | Early Stage VC | $10.0M | ▮ | ▮ |
| Apr 2023 | Early Stage VC | $7.0M | ▮ | ▮ |
| Apr 2023 | Early Stage VC | $12.9M | ▮ | ▮ |
| + 12 earlier rounds · a free account shows the full history | ||||
How PharmaCann's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For PharmaCann, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has PharmaCann raised?
- PharmaCann has raised $533.1M in total funding across 18 recorded rounds.
- When did PharmaCann last raise?
- PharmaCann last raised in Mar 2024 (Early Stage VC), raising $35.0M.